-
- 2023-03-16
- 2023-03-16
- 2023-03-16
- 2023-03-16
-
Target Pathogen to prevent and
Cure Cancer
Target Pathogen to prevent and
Cure Cancer
ABOUT US
Our mission is to combine the regional strengths of Singapore, China and Germany (SCG) and translate state-of-the-art scientific and clinical advances to design and develop novel immunotherapies.
We are a leading global biological company specializing in TCR-T technology for the treatment of pathogen induced solid tumors. The company's core products cover: hepatitis B virus-related liver cancer, Helicobacter pylori-related gastric cancer, HPV virus-induced cervical cancer and others.
● SCG is developing an industry-leading immunotherapy pipeline for the treatment of chronic infections and pathogen-related solid tumors, combining multiple platforms and proprietary insights to provide solutions for patients who need better prevention and treatment of cancer.
OUR PIPELINE
NEWS INFORMATION
The company has far-reaching brand influence
Rich engineering management experience and high-quality service assurance system.
Singapore Add:50 Raffles Place #37-00 Singapore Land Tower, Singapore 048623
Germany Add: Am Klopferspitz 19 #01-05, Planegg Germany 82152
We wholeheartedly provide you with the most convenient platform. For details, please consult:
E-mail: info@scgcell.com